Healthcare has been shifting to a value-based, personalized paradigm,” says Brett Davis, general manager, ConvergeHEALTH by Deloitte. “Reimbursement pressures and the unsustainability of the cost trajectory we’ve been on has been driving everyone to get to more of an outcomes-based…
The Intelligent Trial: AI Comes To Clinical Trials
Artificial intelligence is revolutionizing health care and advancing the clinical trial process faster than any Hollywood AI robot could predict. Besides cutting costs, improving trial quality, and reducing trial times by almost half, AI is finding biomarkers and gene signatures…
Rho, Bracket, Hearst, And More: News From September 2017
September was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Rho, Bracket, Hearst, and more. Hearst announced an equity investment in M2Gen one of the top comprehensive cancer centers in the United States.…
PureTech’s device could rival Saxenda in obesity market
A new non-invasive device from PureTech Health could help millions of overweight or obese people to slim down, allowing them to avoid surgery or prescription treatments. Analysts believe it could also rival Novo Nordisk, the pharmaceutical company whose products are…
In a world of change, big pharma remains a constant
Pfizer, Roche and Novartis top the pharma table – and are set to stay there until at least 2022. Novo Nordisk predicted to deliver the greatest return on investment. But cell and gene therapies, plus AI, digital tech will disrupt…
Facebook just held a breakfast to promote its ‘clinical trials strategy’ to drug marketers
Facebook brought drug marketers together to educate them on targeting consumers. The company is going after an industry that’s rapidly increasing its digital ad spending On Thursday, the company’s New York-based health unit hosted an invitation-only breakfast for pharmaceutical marketers…
Smartphone app looks to tackle US opioid crisis
A smartphone app could help improve pain and addiction management associated with America’s ongoing opioid crisis. According to the National Institutes of Health, more than 25 million – or over one in 10 – Americans experience pain daily. But…
Summit Therapeutics antibiotic delivers encouraging clinical trial results
A phase II clinical trial pitched Summit’s ridinilazole against a specialist (narrow-spectrum) drug, fidaxomicin Summit Therapeutics PLC’s (LON:SUMM, NASDAQ:SMMT) next-generation antibiotic scored well in a head to head with the existing treatment for Clostridium difficile infection (C.difficile). A phase II…
Clinerion, Novartis, RxEOB, And More: News From August 2017
August 31, 2017 | August was full of exciting news in the clinical trial and healthcare community, including partnerships and products from Clinerion, Novartis, RxEOB, and more. RxEOB has authored the case study, “Utilizing RxEOB MercuryMessaging to promote mammograms.” The RxEOB…
Report lays out new strategy for UK life sciences
Industry-led plans to breathe new life into the UK’s £64-billion life sciences sector have been unveiled alongside details of £160 million in government funding to fuel progress in the field. The Life Sciences Industrial Strategy report, penned by immunologist and…
